Diasorin SpA (OTCPK:DSRLF)
$ 99.86 0 (0%) Market Cap: 6.07 Bil Enterprise Value: 6.97 Bil PE Ratio: 32.52 PB Ratio: 3.40 GF Score: 96/100

DiaSorin SpA Investor Day Transcript

Jun 11, 2019 / 12:30PM GMT
Release Date Price: $114.75
Carlo Rosa
DiaSorin S.p.A. - CEO, GM & Executive Director

(foreign language) Welcome to everybody. There are almost 200 people connected to this event through the web, so I welcome who is here and who is not here. And we are going to be spending the next hour or so talking about the next 4 years of DiaSorin but really also talking about the following 4 years because all the investments that we are planning to make in the next 4 years will fuel growth also for the foreseeable future.

So let's start quickly about who are we, and we say that we are a specialist and -- but what does a specialist means? Certainly, it means we are not Roche, that's simple. But a specialist means that we are a company committed to develop products that require complex technology and high-risk research spending. So there is always an investment in research and development and technologies that has been paying off over the last 19 years, and we believe we will continue to pay off for the following 10 years. And our customer base has always recognized this connotation of the company.

We are really global. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot